09-1-2793 US producer questionnaire

OMB No. 3117-0016/USITC No. 10-1-2793; Expiration Date: 6/30/2011
(No response is required if currently valid OMB control number is not displayed)

U.S. PRODUCERS’ QUESTIONNAIRE
CERTAIN SODIUM AND POTASSIUM PHOSPHATE SALTS FROM CHINA

This questionnaire must be received by the Commission by no later than October 8, 2009
See page 4 of the Instruction Booklet for filing instructions.
The information called for in this questionnaire is for use by the United States International Trade Commission in
connection with its countervailing duty and antidumping investigations concerning certain sodium and potassium
phosphate salts (“certain phosphate salts”) from China (Inv. Nos. 701-TA-473 and 731-TA-1173 (Preliminary)). The
information requested in the questionnaire is requested under the authority of the Tariff Act of 1930, title VII. This report
is mandatory and failure to reply as directed can result in a subpoena or other order to compel the submission of records or
information in your possession (19 U.S.C. § 1333(a)).

Name of firm
Address
State

City

Zip Code

World Wide Web address
Has your firm produced certain phosphate salts (as defined in the instruction booklet) at any time since January 1,
2006?

NO

(Sign the certification below and promptly return only this page of the questionnaire to the Commission)

YES

(Read the instruction booklet carefully, complete all parts of the questionnaire, and return the entire
questionnaire to the Commission so as to be received by the date indicated above)

CERTIFICATION
I certify that the information herein supplied in response to this questionnaire is complete and correct to the best of my knowledge
and belief and understand that the information submitted is subject to audit and verification by the Commission.
By means of this certification I also grant consent for the Commission, and its employees and contract personnel, to use the
information provided in this questionnaire and throughout these investigations in any other import-injury investigations conducted
by the Commission on the same or similar merchandise.
I acknowledge that information submitted in this questionnaire response and throughout these investigations may be used by the
Commission, its employees, and contract personnel who are acting in the capacity of Commission employees, for developing or
maintaining the records of these investigations or related proceedings for which this information is submitted, or in internal audits
and investigations relating to the programs and operations of the Commission pursuant to 5 U.S.C. Appendix 3. I understand that
all contract personnel will sign non-disclosure agreements.

Name of Authorized Official

Title of Authorized Official
Phone: (

Date

)

Signature

E-mail address
Fax (

)

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 2

PART I.—GENERAL INFORMATION
The questions in this questionnaire have been reviewed with market participants to ensure that issues of
concern are adequately addressed and that data requests are sufficient, meaningful, and as limited as
possible. Public reporting burden for this questionnaire is estimated to average 50 hours per response,
including the time for reviewing instructions, searching existing data sources, gathering the data needed,
and completing and reviewing the questionnaire. Send comments regarding the accuracy of this burden
estimate or any other aspect of this collection of information, including suggestions for reducing the
burden, to the Office of Investigations, U.S. International Trade Commission, 500 E Street, SW,
Washington, DC 20436.
I-1a.

Please report below the actual number of hours required and the cost to your firm of preparing the
reply to this questionnaire and completing the form.
hours

dollars

I-1b.

We are interested in any comments you may have for improving this questionnaire in general or
the clarity of specific questions. Please attach such comments to your response or send them to
the above address.

I-2.

Provide the name and address of establishment(s) covered by this questionnaire (see page 3 of the
instruction booklet for reporting guidelines). If your firm is publicly traded, please specify the
stock exchange and trading symbol.

I-3.

Do you support or oppose the petition?
Support

Oppose

Take no position

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 3

PART I.--GENERAL INFORMATION--Continued
I-4.

Is your firm owned, in whole or in part, by any other firm?
No

Firm name

I-5.

Address

Extent of
ownership

Does your firm have any related firms, either domestic or foreign, which are engaged in
importing certain phosphate salts from China into the United States or which are engaged in
exporting certain phosphate salts from China to the United States?
No
Firm name

I-6.

Yes--List the following information

Yes--List the following information
Address

Affiliation

Does your firm have any related firms, either domestic or foreign, which are engaged in the
production of certain phosphate salts?
No
Firm name

Yes--List the following information
Address

Affiliation

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 4

PART II.—TRADE AND RELATED INFORMATION
Further information on this part of the questionnaire can be obtained from Jennifer Merrill (202-2053188, [email protected]). Supply all data requested on a calendar-year basis.
II-1.

Who should be contacted regarding the requested trade and related information?
Company contact:
Name and title
(
)
Phone number

II-2.

E-mail address

Has your firm experienced any plant openings, relocations, expansions, acquisitions,
consolidations, closures, or prolonged shutdowns because of strikes or equipment failure;
curtailment of production because of shortages of materials; or any other change in the character
of your operations or organization relating to the production of certain phosphate salts since
January 1, 2006?
No
Yes--Supply details as to the products involved (DKP, MKP, STPP, and/or
TKPP), the time, nature, and significance of such changes.

II-3.

Does your firm produce other products on the same equipment and machinery, or with the same
production and related workers, that produce certain phosphate salts?
No

Yes--List the following information.

Basis for allocation of capacity data (e.g., production volume):
Products produced on same equipment and share of total production in 2008 (in percent):
Product

Share (%) Product

DKP

Total

Share (%) Product

MKP

100.0

Total

Share (%) Product

STPP

100.0

Total

Share (%)

TKPP

100.0

Total

100.0

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 5

PART II.—TRADE AND RELATED INFORMATION
II-4.

Please describe the constraint(s) that set the limit(s) on your production capacity and your ability
to shift production capacity between products (including but not limited to the specified
phosphate salts).

II-5.

Since January 1, 2006, has your firm been involved in a toll agreement (see definition in the
instruction booklet) regarding the production of certain phosphate salts?
No

II-6.

.

Does your firm produce certain phosphate salts in a foreign trade zone (FTZ)?
No

II-7.

Yes--Name firm(s):

Yes--Identify FTZ(s):

Since January 1, 2006, has your firm imported certain phosphate salts?
No

Yes--COMPLETE AND RETURN A U.S. IMPORTERS’
QUESTIONNAIRE

.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 6

PART II.—TRADE AND RELATED INFORMATION--Continued
II-8a. Report your firm’s production capacity, production, shipments, inventories, and employment
related to the production of DKP in your U.S. establishment(s) during the specified periods. (See
definitions in the instruction booklet.)

DKP
Quantity (in 1,000 lbs. dry weight) and value (in $1,000)
Calendar years
Item

2006

2007

January-June
2008

2008

2009

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for each of the periods noted above:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 7

PART II.—TRADE AND RELATED INFORMATION--Continued
II-8b.

Report your firm’s production capacity, production, shipments, inventories, and employment
related to the production of MKP in your U.S. establishment(s) during the specified periods.
(See definitions in the instruction booklet.)

MKP
Quantity (in 1,000 lbs. dry weight) and value (in $1,000)
Calendar years
Item

2006

2007

January-June
2008

2008

2009

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for each of the periods noted above:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 8

PART II.—TRADE AND RELATED INFORMATION--Continued
II-8c.

Report your firm’s production capacity, production, shipments, inventories, and employment
related to the production of STPP in your U.S. establishment(s) during the specified periods.
(See definitions in the instruction booklet.)

STPP
Quantity (in 1,000 lbs. dry weight) and value (in $1,000)
Calendar years
Item

2006

2007

January-June
2008

2008

2009

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for each of the periods noted above:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 9

PART II.—TRADE AND RELATED INFORMATION--Continued
II-8d.

Report your firm’s production capacity, production, shipments, inventories, and employment
related to the production of TKPP in your U.S. establishment(s) during the specified periods.
(See definitions in the instruction booklet.)

TKPP
Quantity (in 1,000 lbs. dry weight) and value (in $1,000)
Calendar years
Item

2006

2007

January-June
2008

2008

2009

1

Average production capacity (quantity)
Beginning-of-period inventories (quantity)
Production (quantity)
U.S. shipments:
Commercial shipments:
Quantity of commercial shipments
Value of commercial shipments
Internal consumption:
Quantity of internal consumption
Value2 of internal consumption
Transfers to related firms:
Quantity of transfers
Value2 of transfers
Export shipments:3
Quantity of export shipments
Value of export shipments
End-of-period inventories4 (quantity)
Channels of distribution:
U.S. shipments to distributors (quantity)
U.S. shipments to end users (quantity)
Employment data:
Average number of PRWs (number)
Hours worked by PRWs (1,000 hours)
Wages paid to PRWs (value)
1

The production capacity (see definitions in instruction booklet) reported is based on operating
hours per week,
weeks per year. Please describe the methodology used to calculate production capacity, and explain any changes in
reported capacity (use additional pages as necessary).
2

Internal consumption and transfers to related firms must be valued at fair market value. In the event that you use a
different basis for valuing these transactions, please specify that basis (e.g., cost, cost plus, etc.) and provide value data
using that basis for each of the periods noted above:
3

Identify your principal export markets:
.
Reconciliation of data.--Please note that the quantities reported above should reconcile as follows: beginning-of-period
inventories, plus production, less total shipments, equals end-of-period inventories. Do the data reported reconcile?
4

Yes

No--Please explain:

.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 10

PART II.—TRADE AND RELATED INFORMATION--Continued
II-9.

If you reported transfers to related firms in question II-8 a,b,c, or d, please indicate the nature of
the relationship between your firm and the related firms (e.g., joint venture, wholly owned
subsidiary), whether the transfers were priced at market value or by a non-market formula,
whether your firm retained marketing rights to all transfers, and whether the related firms also
processed inputs from sources other than your firm.

II-10.

Phosphate salts in solution. Please report the quantity (1,000 lbs dry weight) and value ($1,000)
of your firm’s 2008 U.S. shipments of phosphate salts in solution. Such shipments should be
included in your responses to questions II-8 c and d, for STPP and TKPP, but should not be
included in your responses to questions II-8a and II-8b for DKP and MKP.
China 2008

Product
DKP

Quantity

1

MKP1
STPP
TKPP
1

Not subject to these investigations

Other Sources 2008
Value

Quantity

Value

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 11

PART II.—TRADE AND RELATED INFORMATION--Continued
II-11a. Other than direct imports, has your firm otherwise purchased DKP since January 1, 2006? (See
definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 lbs. dry weight, value in $1,000)
Calendar years
Item

2006

PURCHASES FROM U.S. IMPORTERS
OF DKP FROM--

2007

January-June
2008

2008

2009

2

CHINA:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:

2

Quantity
Value
1

2

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 12

PART II.—TRADE AND RELATED INFORMATION--Continued
II-11b. Other than direct imports, has your firm otherwise purchased MKP since January 1, 2006? (See
definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 lbs. dry weight, value in $1,000)
Calendar years
Item

2006

PURCHASES FROM U.S. IMPORTERS
OF MKP FROM--

2007

January-June
2008

2008

2009

2

CHINA:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:

2

Quantity
Value
1

2

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 13

PART II.—TRADE AND RELATED INFORMATION--Continued
II-11c. Other than direct imports, has your firm otherwise purchased STPP since January 1, 2006? (See
definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 lbs. dry weight, value in $1,000)
Calendar years
Item

2006

PURCHASES FROM U.S. IMPORTERS
OF STPP FROM--

2007

January-June
2008

2008

2009

2

CHINA:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:

2

Quantity
Value
1

2

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 14

PART II.—TRADE AND RELATED INFORMATION--Continued
II-11d. Other than direct imports, has your firm otherwise purchased TKPP since January 1, 2006? (See
definitions in the instruction booklet.)
Yes--Report such purchases below for the specified periods.1

No

(Quantity in 1,000 lbs. dry weight, value in $1,000)
Calendar years
Item

2006

PURCHASES FROM U.S. IMPORTERS
OF TKPP FROM--

2007

January-June
2008

2008

2009

2

CHINA:
Quantity
Value
All other countries:
Quantity
Value
PURCHASES FROM DOMESTIC
2
PRODUCERS:
Quantity
Value
PURCHASES FROM OTHER SOURCES:

2

Quantity
Value
1

2

Please indicate your reasons for purchasing this product. If your reasons differ by source, please elaborate.

Please list the name of the firm(s) from which you purchased this product. If your suppliers differ by source,
please identify the source for each listed supplier.

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 15

PART III.--FINANCIAL INFORMATION
Address questions on this part of the questionnaire to Justin Jee (202-205-3186, [email protected]).
III-1.

Who should be contacted regarding the requested financial information?
Company contact:
Name and title
(
)
(
)
_
Phone number & Fax number E-mail address

III-2.

Briefly describe your financial accounting system.
A.

When does your fiscal year end (month and day)?
If your fiscal year changed during the period examined, explain below:

B.1.

Describe the lowest level of operations (e.g., plant, division, company-wide) for
which financial statements are prepared that include subject merchandise:

2.
3.

4.

Does your firm prepare profit/loss statements for the subject merchandise:
Yes
No
How often did your firm (or parent company) prepare financial statements
(including annual reports, 10Ks)? Please check relevant items below.
Audited,
unaudited,
annual reports,
10Ks,
10 Qs,
Monthly,
quarterly,
semi-annually,
annually
Accounting basis:
GAAP,
cash,
tax, or
other comprehensive
(specify)

Note: The Commission may request that your company submit copies of its financial statements,
including internal profit-and-loss statements for the division or product group that includes
certain phosphate salts, as well as those statements and worksheets used to compile data for your
firm’s questionnaire response.

III-3.

Briefly describe your cost accounting system (e.g., standard cost, job order cost, etc.).

III-4.

Briefly describe your allocation basis, if any, for COGS, SG&A, and interest expense and other
income and expenses.

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 16

PART III.--FINANCIAL INFORMATION--Continued
III-5.

Other products.--Please list any other products you produced in the facilities in which you
produced certain phosphate salts, and provide the share of net sales accounted for by these other
products in your most recent fiscal year:
Products

III-6.

Share of sales

Does your firm receive inputs (raw materials, labor, energy, or any other services) used in the
production of certain phosphate salts from any related firm?
Yes—Continue to question III-7 below.

III-7.

In the space provided below, identify the inputs related to the production of certain phosphate
salts that your firm receives from related parties whose financial statements are consolidated with
the financial statements of your firm.
Input

III-8.

No--Continue to question III-10 below.

Related party

With respect to the related companies identified in response to question III-7 above, are their
financial statements consolidated with your firm’s financial statements? (In other words, are
profits or losses arising from intercompany transactions eliminated?
Yes—Continue to question III-9 below.

No--Continue to question III-10 below.

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 17

PART III.--FINANCIAL INFORMATION--Continued
III-9.

All intercompany profit on inputs purchased from related parties that is eliminated pursuant to
formal financial statement consolidation should also be eliminated from the costs reported to the
Commission in questions III-11a-d (i.e., costs reported in questions III-11a-d, to the extent that
they reflect inputs purchased from related parties, should only reflect the related party’s cost and
not include an associated profit component). Reasonable methods for determining and
eliminating the associated profit on inputs purchased from related parties are acceptable.
Has your firm complied with the Commission’s instructions regarding costs associated with
inputs purchased from related parties?
Yes

No—Please contact Justin Jee (202-205-3186, [email protected]).

III-10. Nonrecurring charges.--For each annual period for which financial results are reported in
questions III-11a-d, please indicate in the schedule below the specific nonrecurring charges, the
particular expense/cost line items from questions III-11a-d where the associated charges are
included, a brief description of the charges, and the associated values (in $1,000). Nonrecurring
charges would include, but are not limited to, items such as asset write-offs and accelerated
depreciation due to restructuring of the company’s certain phosphate salts operations.
Fiscal years ended-Item
Non-recurring charges: (In this column please
provide a brief description of each nonrecurring
charge and indicate the particular expense line items
where the associated charges are included in
questions III-11a-d.)
1.
2.
3.
4.
5.
6.
7.

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 18

PART III.--FINANCIAL INFORMATION--Continued
III-11a. Operations on DKP.--Report the revenue and related cost information requested below on DKP
operations of your U.S. establishment(s).1 Do not report resales of products. Note that internal
consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed fiscal
years in chronological order from left to right, and for the specified interim periods. If your firm
was involved in tolling operations (either as the toller or as the tollee) please contact Justin Jee at
(202) 205-3186 before completing this section of the questionnaire.
Quantity (in 1,000 lbs dry weight) and value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 19

PART III.--FINANCIAL INFORMATION--Continued
III-11b. Operations on MKP.--Report the revenue and related cost information requested below on MKP
operations of your U.S. establishment(s).1 Do not report resales of products. Note that internal
consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed fiscal
years in chronological order from left to right, and for the specified interim periods. If your firm
was involved in tolling operations (either as the toller or as the tollee) please contact Justin Jee at
(202) 205-3186 before completing this section of the questionnaire.
Quantity (in 1,000 lbs dry weight) and value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 20

PART III.--FINANCIAL INFORMATION--Continued
III-11c. Operations on STPP.--Report the revenue and related cost information requested below on STPP
operations of your U.S. establishment(s).1 Do not report resales of products. Note that internal
consumption and transfers to related firms must be valued at fair market value and purchases
from related firms must be at cost.2 Provide data for your three most recently completed fiscal
years in chronological order from left to right, and for the specified interim periods. If your firm
was involved in tolling operations (either as the toller or as the tollee) please contact Justin Jee at
(202) 205-3186 before completing this section of the questionnaire.
Quantity (in 1,000 lbs dry weight) and value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 21

PART III.--FINANCIAL INFORMATION--Continued
III-11d. Operations on TKPP.--Report the revenue and related cost information requested below on
TKPP operations of your U.S. establishment(s).1 Do not report resales of products. Note that
internal consumption and transfers to related firms must be valued at fair market value and
purchases from related firms must be at cost.2 Provide data for your three most recently
completed fiscal years in chronological order from left to right, and for the specified interim
periods. If your firm was involved in tolling operations (either as the toller or as the tollee) please
contact Justin Jee at (202) 205-3186 before completing this section of the questionnaire.
Quantity (in 1,000 lbs dry weight) and value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Net sales quantities:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales quantities
Net sales values:3
Commercial sales
Internal consumption
Transfers to related firms
Total net sales values
Cost of goods sold (COGS):4
Raw materials
Direct labor
Other factory costs
Total COGS
Gross profit or (loss)
Selling, general, and administrative
(SG&A) expenses:
Selling expenses
General and administrative expenses
Total SG&A expenses
Operating income (loss)
Other income and expenses:
Interest expense
All other expense items
All other income items
All other income or expenses, net
Net income or (loss) before income taxes
Depreciation/amortization included above
1

Include only sales (whether domestic or export) and costs related to your U.S. manufacturing operations.
Please list the expense categories and amounts of any profits on internal inputs or inputs from related firms that are reflected on
your books but which are eliminated from the costs reported below.
3
Less discounts, returns, allowances, and prepaid freight. The quantities and values should approximate the corresponding
shipment quantities and values reported in Part II of this questionnaire.
4
COGS should include costs associated with internal consumption and transfers to related firms.
2

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 22

PART III.--FINANCIAL INFORMATION--Continued
III-12. Asset values.--Report the total assets associated with the production, warehousing, and sale of
certain phosphate salts. If your firm does not maintain some or all of the specific asset data in the normal
course of business, please estimate it based upon some rational method (such as production, sales, or
costs) that is consistent with your cost allocations in the previous question. Provide data as of the end of
your three most recently completed fiscal years in chronological order from left to right.
Please prepare this asset value table for each product unless such allocation/estimate for each product
is not possible (please explain why it is not possible if asset value can not be prepared for each product).
Fiscal years ended-Item
Assets associated with the production,
warehousing, and sale of product:
1. Current assets:
A. Cash and equivalents
B. Accounts receivable, net
C. Inventories
D. All other current assets
E. Total current assets (lines 1.A. through
1.D.)
2. Non-current assets:
Property, plant, and equipment (PPE):
A. Original cost of PPE
B. Less: Accumulated depreciation
C. Equals: Net book value of PPE
D. All other non-current assets
E. Total non-current assets (lines 2.C +2.D.)
3. Total assets (lines 1.E. and 2.E.)

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 23

PART III.--FINANCIAL INFORMATION--Continued
III-13a. Capital expenditures and research and development expenditures.--Report your firm’s capital
expenditures and research and development expenditures on DKP. Provide data for your three most
recently completed fiscal years in chronological order from left to right, and for the specified interim
periods.
Value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Capital expenditures
Research and development expenditures

III-13b. Capital expenditures and research and development expenditures.--Report your firm’s capital
expenditures and research and development expenditures on MKP. Provide data for your three most
recently completed fiscal years in chronological order from left to right, and for the specified interim
periods.
Value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Capital expenditures
Research and development expenditures

III-13c. Capital expenditures and research and development expenditures.--Report your firm’s capital
expenditures and research and development expenditures on STPP. Provide data for your three most
recently completed fiscal years in chronological order from left to right, and for the specified interim
periods.
Value (in $1,000)
Fiscal years ended-Item

January-June
2008

2009

Capital expenditures
Research and development expenditures

III-13d. Capital expenditures and research and development expenditures.--Report your firm’s capital
expenditures and research and development expenditures on TKPP. Provide data for your three most
recently completed fiscal years in chronological order from left to right, and for the specified interim
periods.
Value (in $1,000)
Fiscal years ended-Item
Capital expenditures
Research and development expenditures

January-June
2008

2009

Business Proprietary
U.S. Producers’ Questionnaire – Certain sodium and potassium phosphate salts

Page 24

PART III.--FINANCIAL INFORMATION--Continued
III-14. Since January 1, 2006, has your firm experienced any actual negative effects on its return on
investment or its growth, investment, ability to raise capital, existing development and production efforts
(including efforts to develop a derivative or more advanced version of the product), or the scale of capital
investments as a result of imports of certain phosphate salts from China?
No

Yes--My firm has experienced actual negative effects as follows:
DKP

MKP STPP TKPP

Cancellation, postponement, or rejection of expansion projects
Denial or rejection of investment proposal
Reduction in the size of capital investments
Rejection of bank loans
Lowering of credit rating
Problem related to the issue of stocks or bonds
Other (specify)
Other (specify)
Other (specify)
Other (specify)

DKP
MKP
STPP
TKPP

III-15. Does your firm anticipate any negative impact of imports of certain phosphate salts from China?
DKP

MKP

STPP

TKPP

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 25

PART IV.—PRICING AND MARKET FACTORS
Further information on this part of the questionnaire can be obtained from Craig Thomsen (202-205-3226,
[email protected])
IV-1.

Contact information (Price).--Who should be contacted regarding the requested pricing and
related information?
Company contact:
Name and title
(
)
Phone number

E-mail address

PRICE DATA
This section requests quarterly quantity and value data, f.o.b. your U.S. point of shipment, for your
commercial shipments to unrelated U.S. customers during January 2006–June 2009 of the following
products produced by your firm.
Product 1.—Dipotassium phosphate (DKP), anhydrous, food grade, whether granular or
powder and regardless of packaging size
Product 2.—Monopotassium phosphate (MKP), anhydrous, technical grade, whether
granular or powder and regardless of packaging size
Product 3.—Sodium tripolyphosphate (STPP), anhydrous, food grade, whether granular or
powder and regardless of packaging size
Product 4.—Sodium tripolyphosphate (STPP), anhydrous, technical grade, whether
granular or powder and regardless of packaging size
Product 5.—Tetrapotassium pyrophosphate (TKPP), anhydrous, food grade, whether
granular or powder and regardless of packaging size
Product 6.—Tetrapotassium pyrophosphate (TKPP), anhydrous, technical grade, whether
granular or powder and regardless of packaging size
Please note that total dollar values should be f.o.b., U.S. point of shipment and should not include
U.S.-inland transportation costs. Total dollar values should reflect the final net amount paid to you
(i.e., should be net of all deductions for discounts or rebates). See the instruction booklet.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 26

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-2.

Report below the quarterly price data1 for pricing products2 produced and sold by your firm.

Period of shipment
2006:
January-March
April-June
July-September
October-December
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
Period of shipment

Quantity in lbs. dry weight, value in dollars)
Product 1
Product 2
Quantity
Value
Quantity
Value

Product 3
Quantity
Value

Product 4
Quantity
Value

Product 6
Quantity
Value

Product 5
Quantity
Value

2006:
January-March
April-June
July-September
October-December
2007:
January-March
April-June
July-September
October-December
2008:
January-March
April-June
July-September
October-December
2009:
January-March
April-June
1

Net values (i.e., gross sales values less all discounts, allowances, rebates, prepaid freight, and the value of returned goods), f.o.b. your U.S. point
of shipment.
2
Pricing product definitions are provided on the first page of Part IV.
Note.--If your product does not exactly meet the product specifications but is competitive with the specified product, provide a description of your product:
Product 1:
Product 2:
Product 3:
Product 4:
Product 5:
Product 6:

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 27

PART IV.—PRICING AND MARKET FACTORS--Continued
PLEASE NOTE:
For the remaining questions in Part IV, please answer separately for DKP, MKP, STPP, and
TKPP, unless the answer for all four certain sodium and potassium phosphate salts are the same.
Some questions have already been prepared for separate answers. Please answer with respect to all
products with which you are familiar.
IV-3.

Price setting.-- How does your firm determine the prices that it charges for sales of certain
sodium and potassium phosphate salts (check all that apply)? If your firm issues price lists,
please include a copy of a recent price list with your submission. If your price list is large, please
only submit some sample pages.
Transaction by transaction

Contracts

Set price lists

Other--Please describe:

IV-4.

Discount policy.-- Please indicate and describe your firm’s discount policies (check all that
apply).
Quantity discounts

Annual total volume discounts

No discount policy

Other--Please describe:

IV-5.

Pricing terms for certain sodium and potassium phosphate salts.-(a)

What are your firm’s typical sales terms for its imported certain sodium and potassium
phosphate salts (e.g., 2/10 net 30 days)?
.

(b)

On what basis are your prices of imported certain sodium and potassium phosphate salts
usually quoted? (check one)
F.o.b.--Please specify point:
Delivered

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 28

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-6.

Contract versus spot.--Approximately what share of your firm’s sales of its imported certain
sodium and potassium phosphate salts in 2008 were on a (1) long-term contract basis (multiple
deliveries for more than 12 months), (2) short-term contract basis (multiple deliveries up to and
including 12 months), and (3) spot sales basis (for a single delivery)?
Type of sale

Share of sales (percent)

Long-term contracts
Short-term contracts
Spot sales
IV-7.

IV-8.

IV-9.

Long-term contact provisions.--If you sell on a long-term contract basis, please answer the
following questions with respect to provisions of a typical long-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

Yes

Quantity

No
Price

Yes

Both
No

Short-term contract provisions.--If you sell on a short-term contract basis, please answer the
following questions with respect to provisions of a typical short-term contract.
(a)

What is the average duration of a contract?

(b)

Can prices be renegotiated during the contract period?

(c)

Does the contract fix quantity, price, or both?

(d)

Does the contract have a meet or release provision?

Yes

Quantity

No
Price

Yes

Both
No

Lead times.--What is the average lead time between a customer’s order and the date of delivery
for your firm’s sales of certain sodium and potassium phosphate salts?

Source

Share of sales,
2008

From your firm’s inventory
Produced to order
Total

100 %

Lead time

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 29

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-10. Shipping information.-(a)

What is the approximate percentage of the total delivered cost of certain sodium and
potassium phosphate salts that is accounted for by U.S. inland transportation costs?
percent.

(b)

Who generally arranges the transportation to your customers’ locations? (check one)
Your firm
or purchaser

(c)

What proportion of your sales are delivered within 100 miles of your production facility
( ) or storage facility ( ) (check one, then provide the percentages)?
percent.
Within 101 to 1,000 miles?
percent. Over 1,000 miles?
percent. Be sure to
check one of the two options for measurement.

IV-11. Geographical Area.--What is the geographic market area in the United States served by your
firm’s certain sodium and potassium phosphate salts? (check all that apply)
Geographic area

√ if applicable

Northeast.–CT, ME, MA, NH, NJ, NY, PA, RI, and VT.
Midwest.–IL, IN, IA, KS, MI, MN, MO, NE, ND, OH, SD, and WI.
Southeast.–AL, DE, DC, FL, GA, KY, MD, MS, NC, SC, TN, VA, and WV.
Central Southwest.–AR, LA, OK, and TX.
Mountains.–AZ, CO, ID, MT, NV, NM, UT, and WY.
Pacific Coast.–CA, OR, and WA.
Other.–All other markets in the United States not previously listed, including AK, HI,
PR, VI, among others.

IV-12. End uses.--Describe the end uses of each of the certain sodium and potassium phosphate salts
that you produce. For each end-use product, what percentage of the total cost is accounted for by
certain sodium and potassium phosphate salts? Please note: these are shares of end-use product
cost, not shares of your firm’s sales, and therefore should NOT add to 100.
DKP:
Share of total cost of end
product (percent)

End use

MKP:
End use

Share of total cost of end
product (percent)

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 30

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-12.

STPP:
Share of total cost of end
product (percent)

End use

TKPP:
Share of total cost of end
product (percent)

End use

IV-13. Changes in end uses.--Have there been any changes in the end uses of certain sodium and
potassium phosphate salts since January 1, 2006?
DKP:

No

Yes--Please describe.

MKP:

No

Yes--Please describe.

STPP:

No

Yes--Please describe.

TKPP:

No

Yes--Please describe.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 31

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-14. Anticipated changes in end uses.--Do you anticipate any changes in terms of the end uses of
certain sodium and potassium phosphate salts in the future?
DKP:

No

Yes

MKP:

No

Yes

STPP:

No

Yes

TKPP:

No

Yes

For each “Yes” answer above, please describe and identify the time period.

IV-15. Substitutes.—
(a)

Can other products be substituted for certain sodium and potassium phosphate salts?
DKP:

No

Yes

MKP:

No

Yes

STPP:

No

Yes

TKPP:

No

Yes

For each “Yes” response above, please list these substitute products in order of
importance and give examples of applications and end uses for which they are substitutes.
DKP:

MKP:

STPP:

TKPP:

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 32

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-15 (b)

Have changes in the prices of these substitute products affected the price for certain
sodium and potassium phosphate salts?
DKP:

No

Yes

MKP:

No

Yes

STPP:

No

Yes

TKPP:

No

Yes

For each “Yes” response above, please describe to what degree the changes in the prices
of substitutes affect the price for each of the certain sodium and potassium phosphate
salts? Does this effect have a time lag? If so, how long is the time lag for each substitute
product?
DKP:

MKP:

STPP:

TKPP:

IV-16. Changes in substitutes.--Since January 1, 2006, have there been any changes in the number or
types of products that can be substituted for certain sodium and potassium phosphate salts?
DKP:

No

Yes--Please explain.

MKP:

No

Yes--Please explain.

STPP:

No

Yes--Please explain.

TKPP:

No

Yes--Please explain.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 33

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-17. Demand trends.-(a)

(b)

How has the demand within the United States for certain sodium and potassium
phosphate salts changed since January 1, 2006? What principal factors affect changes in
demand for each of the products?
DKP:

Increased

No Change

Decreased

Fluctuated

MKP:

Increased

No Change

Decreased

Fluctuated

STPP:

Increased

No Change

Decreased

Fluctuated

TKPP:

Increased

No Change

Decreased

Fluctuated

How has the demand outside the United States (if known) for certain sodium and
potassium phosphate salts changed since January 1, 2006? What principal factors affect
changes in demand outside the United States for each of the products?
DKP:

Increased

No Change

Decreased

Fluctuated

MKP:

Increased

No Change

Decreased

Fluctuated

STPP:

Increased

No Change

Decreased

Fluctuated

TKPP:

Increased

No Change

Decreased

Fluctuated

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 34

PART IV.—PRICING AND MARKET FACTORS--Continued

IV-18. Raw materials.--Please describe any trends in the prices of raw materials used to produce certain
sodium and potassium phosphate salts, and what future trends your firm expects.

IV-19. Changes in factors affecting supply.--Have any changes occurred in any other factors affecting
supply (e.g., changes in availability or prices of energy or labor; transportation conditions;
production capacity and/or methods of production; technology; export markets; or alternative
production opportunities) that affected the availability of U.S.-produced certain sodium and
potassium phosphate salts in the U.S. market since 2006?
No

Yes--Please note the time period(s) of any such changes, the factors(s)
involved, and the impact such changes had on your shipment volumes
and prices.

IV-20. Product changes.--Since January 1, 2006, have there been any significant changes in the product
range, product mix, or marketing (including sales over the internet) of certain sodium and
potassium phosphate salts?
No

DKP:

MKP:

STKP:

TKPP:

Yes--Please describe and quantify if possible for each type of salt for which
you are answering “Yes.”

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 35

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-21. Supply constraints.--Has your firm refused, declined, or been unable to supply certain sodium
and potassium phosphate salts since January 1, 2006? (Examples may include placing customers
on allocation, declining to accept new customers or renew existing customers, delivering less than
the quantity promised, being unable to meet timely shipment commitments, etc.)
No

Yes-- Please note and document the time period(s) (i.e., month and year),
country of origin, the customer involved, and the amount and type of
product involved.

IV-22. Business cycles.-(a) Are the markets for certain sodium and potassium phosphate salts subject to business cycles or
conditions of competition (including seasonal business) distinctive to certain sodium and
potassium phosphate salts?
No (skip to question IV-23)

Yes-- Please describe below, referencing which salt(s)
and then answer part (b).

(b) If yes, have there been any changes in the business cycles or conditions of competition for
certain sodium and potassium phosphate salts since January 1, 2006?
No

Yes-- Please describe, including which salt(s) have had changes.

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 36

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-23. Interchangeability.--Are certain sodium and potassium phosphate salts produced in the United
States and in other countries interchangeable (i.e., can they physically be used in the same
applications)? Please indicate below, using “A” to indicate that the products from a specified
country-pair are always interchangeable, “F” to indicate that the products are frequently
interchangeable, “S” to indicate that the products are sometimes interchangeable, “N” to indicate
that the products are never interchangeable, and “0” to indicate no familiarity with products from
a specified country-pair.1
DKP:

China

Other countries

China

Other countries

China

Other countries

China

Other countries

United States
China
MKP:
United States
China
STPP:
United States
China
TKPP:
United States
China
1

For any country-pair for which certain sodium and potassium phosphate salts are sometimes or
never interchangeable, please explain the factors that limit or preclude interchangeable use:

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 37

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-24. Differences other than price by country-pair.--Are differences other than price (i.e., quality,
availability, transportation network, product range, technical support, etc.) between certain
sodium and potassium phosphate salts produced in the United States and in other countries a
significant factor in your firm’s sales of the products? Please indicate below, using “A” to
indicate that such differences are always significant, “F” to indicate that such differences are
frequently significant, “S” to indicate that such differences are sometimes significant, “N” to
indicate that such differences are never significant, and “0” to indicate no familiarity with
products from a specified country-pair.1
DKP:

China

Other countries

China

Other countries

China

Other countries

China

Other countries

United States
China
MKP:
United States
China
STPP:
United States
China
TKPP:
United States
China
1
For any country-pair for which factors other than price always or frequently are a significant factor
in your firm’s sales of certain sodium and potassium phosphate salts, identify the country-pair and report
the advantages or disadvantages imparted by such factors:

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 38

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-25. Purchaser Identification.--Please identify below the names and addresses of your firm’s 5
largest customers for each of the specified sodium and potassium phosphate salts since 2006.
Please also provide the name and telephone number of a contact person and the share of the
quantity of your firm’s total shipments of certain sodium and potassium phosphate salts that each
of these customers accounted for in 2008.
DKP:
No.

Customer’s name

Contact person

Street address (not P.O. box),
city, state, and zip code

Area
code and
telephone
number

Share of
2008
sales
(%)

Contact person

Street address (not P.O. box),
city, state, and zip code

Area
code and
telephone
number

Share of
2008
sales
(%)

1

2

3

4

5

MKP:
No.

1

2

3

4

5

Customer’s name

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 39

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-25. Purchaser Identification (cont.)
STPP:
No.

Customer’s name

Contact person

Street address (not P.O. box),
city, state, and zip code

Area
code and
telephone
number

Share of
2008
sales
(%)

Contact person

Street address (not P.O. box),
city, state, and zip code

Area
code and
telephone
number

Share of
2008
sales
(%)

1

2

3

4

5

TKPP:
No.

1

2

3

4

5

Customer’s name

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 40

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-26. COMPETITION FROM IMPORTS--LOST REVENUES.—
THIS SECTION IS TO BE COMPLETED ONLY BY NON-PETITIONERS. (Note:
petitioners may provide allegations involving quotes made AFTER the filing of the petition.)
Since January 1, 2006: To avoid losing sales to competitors selling certain sodium and potassium
phosphate salts from China, did your firm:
Reduce prices

No

Yes

Roll back announced price increases

No

Yes

If yes, please furnish as much of the following information as possible for each affected
transaction. Document such allegations of lost revenues whenever possible (documentation could
include copies of invoices, sales reports, or letters from customers). Please note that the
Commission may contact the firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your initial price quotation
Quantity involved
Your initial rejected price quotation (total delivered value)
Your accepted price quotation (total delivered value)
The country of origin of the competing imported product
The competing price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and fax
numbers

Product

Date of
quote

Quantity
(1,000 lb.
dry weight)

Initial
rejected U.S.
price (total
value-dollars)

Accepted
U.S. price
(total value-dollars)

Country of
origin

Competing
import price
(total
value—
dollars)

Business Proprietary
U.S. Producers’ Questionnaire - Certain sodium and potassium phosphate salts

Page 41

PART IV.—PRICING AND MARKET FACTORS--Continued
IV-27. COMPETITION FROM IMPORTS--LOST SALES.—
THIS SECTION IS TO BE COMPLETED ONLY BY NON-PETITIONERS. (Note:
petitioners may provide allegations involving quotes made AFTER the filing of the petition.)
Since January 1, 2006: Did your firm lose sales of certain sodium and potassium phosphate salts
to imports of these products from China?
No

Yes

If yes, please furnish as much of the following information as possible for each affected
transaction. Document such allegations of lost sales whenever possible (documentation could
include copies of invoices, sales reports, or letters from customers). Please note that the
Commission may contact the firms named to verify the allegations reported.
Customer name, contact person, phone and fax numbers
Specific product(s) involved
Date of your price quotation
Quantity involved
Your rejected price quotation (total delivered value)
The country of origin of the competing imported product
The accepted price quotation of the imported product (total delivered value)
Customer name,
contact person,
phone and fax
numbers

Product

Date of
quote

Quantity
(1,000 lb.
dry weight)

Rejected
U.S. price
(total value-dollars)

Country of
origin

Competing
import price
(total
value—
dollars)